Innovative Targeting Strategies in Breast Cancer Therapy
- Publisher's listprice EUR 163.99
-
68 014 Ft (64 776 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 13 603 Ft off)
- Discounted price 54 412 Ft (51 821 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
68 014 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 28 October 2025
- ISBN 9780443333491
- Binding Paperback
- No. of pages344 pages
- Size 235x191 mm
- Weight 450 g
- Language English 699
Categories
Long description:
Innovative Targeting Strategies in Breast Cancer Therapy is a comprehensive reference addressing the challenge of non-specific drug distribution in the body, along with severe toxicity and adverse effects, by offering insights into targeted breast cancer treatment. It further educates researchers on formulating and developing novel carriers with target-specific attributes (such as targeted liposomes, nanoparticles, micelles, and dendrimers), contributing to a more refined approach to breast cancer. This book's content is presented in 12 chapters. The first chapters introduces the reader to the different breast cancer therapies followed by indepth information on targeting . Recognizing the need for targeted drug delivery in breast cancer treatment, this book presents an encompassing compilation of advanced research and formulation strategies. By focusing on effectively targeting cancer cells, the book mitigates dose-related toxicity associated with cytotoxic drugs, providing a comprehensive resource for improved treatment approaches. Research in oncology, pharmacology, medical researchers, biomedical engineers and clinical professionals will find this an essential reference.
MoreTable of Contents:
1. Chemotherapeutic drugs and its side effects, breast cancer biomarkers, detection, level of targeting and EPR effect
2. Receptor-ligand based targeting approaches breast cancer
3. Stimuli-based targeting breast cancer
4. Advance strategies for targeting severe triple-negative breast cancer
5. Targeted therapy for BRCA gene mutations breast cancer
6. Androgen receptor targeted therapy for breast cancer
7. Monoclonal antibodies-based breast cancer targeting
8. Breast cancer stem cell targeting
9. The Role of Hormone Receptors in Breast Cancer: New opportunities for Treatment and Prevention
10. HER2-positive and HER2-negative Targeted Therapies
11. Immunotherapy for breast cancer
12. Current market formulation, therapy in clinical trails, and status of IPR for breast cancer
The Plymouth Colony
2 880 HUF
2 650 HUF
